Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma
Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma
Active, not recruiting · NCT00470223 · Registry updated 2025-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Active, not recruiting | Phase 3 | 2025-06-08 | NCT00470223 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chugai Pharmaceutical | 25 |
| Ligue contre le cancer, France | 19 |
| National Cancer Institute, France | 61 |
| Novartis | 114 |
| SFCE | 1 |
| UNICANCER | 111 |
37 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.